Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Commentary

    The 2020 Coronavirus (COVID-19) Global Pandemic, a Call to Arms to Pharmacognosy Researchers – Plant-Based Antiviral Approaches

    wadmin1By wadmin1January 1, 2021Updated:August 5, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Sean R Alcorn
    School of Pharmacy and Pharmacology, QUM Network, Griffith University, Gold Coast, AUSTRALIA.

    Pharmacognosy Communications,2021,11,1,2-8.
    DOI:10.5530/pc.2021.1.2
    Published: January 2021
    Type: Commentary

    ABSTRACT

    Background: The unprecedented modern pandemic that is COVID-19 has awakened a global fear of viral disease and an activation of viral targeted drug discovery not seen before in modern times. Whilst the vaccines about to enter the market, are an important component of the strategy to combat COVID-19, vaccination should be considered a part of a wider strategy to address this and future zoonotic viral outbreaks. Plant-based approaches may provide valuable avenues for viral disease management. Methods: This commentary combines an appraisal of the existing literature with the authors thoughts on key challenges that pharmacognosy may be able to assist with, in the management of zoonotic viral disease. Results: There are many avenues for plant-based antiviral research in the context of the present COVID-19 pandemic. This narrative review discusses the use of plant-based approaches; as viral drug leads, as agents for managing the cytokine storm associated with acute respiratory distress syndrome, as agents for elimination of viral reservoirs and as agents in hand sanitisation. Conclusion: Whilst the arrival of vaccines is an important step in the response to the current COVID-19 pandemic. Pharmacognosy still has a role to play in the management of this and future viral pandemics. The support of researchers in this domain is needed to combat viral pandemics via arming clinicians with a broader range of options for prevention and treatment of viral illness on a global scale.

    Keywords: Anti-viral agents, Coronavirus, COVID-19, COVID-19 vaccine, Drug discovery, Severe acute respiratory syndrome.
    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up